CIMZIA sol inj 200 mg/ml 2 ser pré 1 ml
7680600960015
CH-60096
L04AB05
07.15.0.
Reimbursement limitations:
CIMZIA5
Traitement de la polyarthrite rhumatoïde active et de l'arthrite psoriasique active en cas de réponse …
1 / 3
google
Details
- Product number
- 6009601
- CPT
- -
- Packaging group
- 2
- Unit
- Spritze(n)
- Composition
- certolizumabum pegolum 200 mg, natrii acetas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.257 mg. Tela cum: alcohol isopropylicus.
Articles (1)
Cimzia, solution injectable
Injektionslösung
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
TEL
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.257 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 986.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2010
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 60096
- Drug name
- Cimzia, solution injectable
- Galenic form
- LSPA
- ATC Code
- L04AB05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 11/06/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CIMZIA sol inj 200 mg/ml 2 ser pré 1 ml
- Description (DE)
- CIMZIA Inj Lös 200 mg/ml 2 Fertspr 1 ml
- Market launch
- 11/06/2010
- Narcotic (BTM)
- No